New Drug Delivery System for OA?

Every day about 27 million Americans battle the pain and debilitating effects of osteoarthritis (OA). Despite an annual economic toll of approximately $128 billion in medical and indirect costs, the best treatments developed so far provide only temporary pain relief. Oral analgesics, non-steroidal anti-inflammatories and injectable glucocorticosteroidal may treat pain temporarily. But they do little for long-term pain relief or for slowing progression of the disease....

To read more, go to:  http://www.arthritis.org/research/funded-research/research-update/new-drug-delivery-model-may-advance-oa-treatment/